Arecor Therapeutics Investor Relations Material
Latest events
H2 2024
Arecor Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Arecor Therapeutics PLC
Access all reports
Arecor Therapeutics PLC is a biopharmaceutical company specializing in the development of enhanced pharmaceutical formulations. The company applies its proprietary technology to improve the stability, efficacy, and delivery of existing biologics, peptides, and therapeutic proteins. Its pipeline includes proprietary and partnered programs focused on diabetes, critical care, and other therapeutic areas. The company is headquartered in Cambridge, United Kingdom, and its shares are listed on the London Stock Exchange (LSE).
Key slides for Arecor Therapeutics PLC
H1 2024
Arecor Therapeutics PLC
H1 2024
Arecor Therapeutics PLC
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
AREC
Country
🇬🇧 United Kingdom